In the present study, we tested the IgG and IgM antibodies to SARS-CoV-2 in children to estimate the infection rate of SARS-CoV-2 in children from mid-December 2022 to mid-January 2023, the pandemic period shortly after the discontinuation of zero-COVID-19 policy in China. The gene discussed is CD40LG; the disease is COVID-19.